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Diarrheal disease is still a main cause of morbidity and mortality in 
children across the world [1]. 
Nosocomial diarrhea is a common complication in inpatients [2]. 
Clostridium difficile is the most common cause of nosocomial 
diarrheal and antibiotics-associated diarrheal diseases [3-5]. 
Hospitalization period of patients was from three to 18 days with 
the mean 5.5±2.21 days. Duration of antibiotic consumption was 
three to 18 days with the mean 5.4±2.1 days. Diarrhea duration 
was from one to three days with mean 1.67±0.56 days. The 
frequency of diseases leading to hospitalization is summarized in 
[Table/Fig-1]. 
Disease Number Percent
Respiratory tract infection 124 62
Fever without localizing sing 27 13.5
Febrile convulsion 12 6
Urinary tract infection 5 2.5
Total 200 100
[Table/Fig-1]: Causes of hospitalization.
The types of antibiotic which were administered to children are 
summarized in [Table/Fig-2].
Antibiotic Number Percent
Cefotaxime 102 51
Ceftriaxone 59 29.5
Cefotaxime+ Vancomicine 10 5
Ceftriaxone + Clindamycin 9 4.5
Clindamycin 5 2.5
Cefotaxime + Clindamycin 5 2.5
Others 10 5
[Table/Fig-2]: Types of antibiotic consumption.
Two patients of positive cases were boy and four were girl. Five 
positive cases were observed among other antibiotic treatments. 
Positive results were not related to sex and age of the patients, 
duration of hospitalization, antibiotic consumption and diarrhea 
(p>0.05). 
In this study the prevalence of nosocomial diarrhea due to C. 
difficile was 6 (3%). 
Statistical tests indicated no significant difference in the ELISA 
positivity prevalence in stool samples of the patients with 
nosocomial regarding for the duration of hospitalization in day. This 
could be due to the low number of ELISA-positive stool samples of 
patients with nosocomial diarrhea.
It is concluded that C. difficile is an important reason for 
nosocomial diarrhea and the most important prescribed antibiotic 
is cefotoxim. Determining the prevalence of C. difficile and the 
types of strategies that can deal with this pathogen is important. 
It is recommended in future studies polymerase chain reaction be 
used to test and determine the strains of bacteria because this 
test is more accurate. 
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ImpLIcATIon oF your mAnuscrIpT
This study investigated the frequency of nosocomial toxicogenic 
C. difficile in children aged less than 5 years.
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